Increase in Transaminase Levels Following the Use of Raltegravir in a Woman With a High HIV Viral Load at 35 Weeks of Pregnancy

Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment

Edward M. Connor, Rhoda Sperling, Richard D. Gelber et al. · New England Journal of Medicine · 1994 · 3.7K citations · Full text

Public Health, Infectious Diseases, Maternal Health +13

Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus 1 with Zidovudine Treatment

Edward M. Connor, Rhoda Sperling, Richard D. Gelber et al. · Obstetrical & Gynecological Survey · 1995 · 1.8K citations

Public Health, Infectious Diseases, Pediatrics +17

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

Laura Guay, Philippa Musoke, Thomas R. Fleming et al. · The Lancet · 1999 · 1.7K citations

Public Health, Maternal Health, Pediatrics +14

Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial

Beatriz Grinsztejn, Bach-Yen Nguyen, Christine Katlama et al. · The Lancet · 2007 · 568 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Infectious Diseases +16

U.S. Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions To Reduce Perinatal HIV-1 Transmission in the United States

Lynne Mofenson · PsycEXTRA Dataset · 2002 · 519 citations

Public Health, Maternal Health, Obstetrics +17